Please login to the form below

Not currently logged in
Email:
Password:

clinical

This page shows the latest clinical news and features for those working in and with pharma, biotech and healthcare.

Chinese biotechs aim PD-L1 antibody at hepatitis B

Chinese biotechs aim PD-L1 antibody at hepatitis B

Suzhou Alphamab is already testing its PD-L1 inhibitor antibody KN035 in a number of clinical trials across tumour types in the US, China and Japan, but has licensed rights for ... Blocking the PD-1/PD-L1 pathway could be an effective immunotherapy

Latest news

More from news
Approximately 183 fully matching, plus 4,003 partially matching documents found.

Latest Intelligence

  • Escaping the spin cycle of sub-optimal launch Escaping the spin cycle of sub-optimal launch

    The most effective drug launches rely not only on a compelling clinical profile but on organisational proficiency and agility across a range of inter- related disciplines.

  • Relearning launch: Four key dynamics for pharma launches in 2019 Relearning launch: Four key dynamics for pharma launches in 2019

    Regional sales managers will move from making decisions on headcount to field force mix (e.g., reimbursement specialist, clinical educator, sales rep, etc.), contact centre strategy and multichannel resources.

  • Is China ready for a pharmaceutical gold rush?

    What’s more, requirements to carry out local clinical trials before being granted access to the Chinese market have relaxed. ... In light of recent clinical data, Keytruda is widely regarded as the better of the two checkpoint inhibitors in lung cancer.

  • AstraZeneca’s oncology renaissance AstraZeneca’s oncology renaissance

    The clinical and commercial success of these three cancer therapies has helped restore self-belief among AstraZeneca employees, and will help make 2019 the year the company returns to top-line ... from clinical trials to FDA approval in just over two

  • Combined immunotherapies – potential and pitfalls Combined immunotherapies – potential and pitfalls

    Clinical challenges All clinical trials are complex irrespective of the type of drug being tested. ... may guide the more rational design of clinical trials to improve immune surveillance and tumour control.”.

More from intelligence
Approximately 12 fully matching, plus 496 partially matching documents found.

Latest appointments

More from appointments
Approximately 3 fully matching, plus 501 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 25 fully matching, plus 430 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

The new UK government-pharma industry pricing agreement – welcome news, but there are lessons to be learnt
...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again – in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics